2024-12-10 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Report

**1) Performance Comparison & Divergence:**

Eli Lilly and Co. (LLY), a pharmaceutical company, has significantly outperformed the S&P 500 (VOO).  The cumulative return for LLY is 601.44%, while the VOO's cumulative return is 121.38%. This represents a substantial divergence.  The provided data shows a maximum divergence of 634.8%, a minimum of -25.2%, a current divergence of 484.8%, and a relative divergence of 77.3%.  This indicates LLY's exceptional performance relative to the broader market.

**2) Current Stock Price:**

The closing price is $826.71 (Last market: $803.21).

**4) Recent Earnings Analysis:**

The provided earnings data shows significant volatility in EPS and relatively stable revenue.

* **Latest Quarterly Results Comparison:**  The most recent quarter (2024-10-30) shows a significantly lower EPS ($1.08) compared to the previous quarter (2024-08-08, $3.29).  There's also a notable difference between the EPS figures reported on 2024-10-30 which shows inconsistency in the data provided. This needs further clarification to conduct a proper analysis.
* **Revenue Growth Trends:** Revenue has generally increased over the past year, though there's a slight dip in the quarter ending 2024-04-30 ($8.77B).  Overall revenue is relatively stable and growing moderately.
* **EPS Trends and Significant Changes:** EPS fluctuates considerably, indicating potential variability in profitability influenced by various business factors. The substantial drop from $3.29 to $1.08 between Q2 and Q3 2024 warrants further investigation. The negative EPS in 2023-11-02 and 2024-10-30 also highlights some periods of loss or reduced profitability, requiring more context for a complete understanding.
* **Beats or Misses:**  Without expected earnings figures, it's impossible to determine whether the reported results beat or missed expectations.

**5) Financial Information Analysis:**

* **Revenue and Profitability:**  Revenue is relatively consistent, fluctuating around $9-11 billion.  Profit margins are consistently high, ranging from 80.42% to 81.02%, indicating strong profitability.  However, a more detailed analysis should be conducted considering the apparent inconsistencies mentioned before.
* **Capital and Profitability:**  Equity has generally increased, but ROE shows significant variability.  The dramatic change from a negative ROE (-0.51%) in 2023-09-30 to a much higher positive ROE in the subsequent quarters implies substantial changes in profitability during that time.  Further investigation into these changes is needed.

**6) News and Recent Issues:**

This section requires additional data.  Information on recent earnings news (within the last two days), market outlook, and analyst opinions is needed to complete this analysis.

**7) Overall Analysis:**

LLY has demonstrated exceptional stock performance compared to the S&P 500, significantly outpacing the market.  However, recent quarterly earnings reports reveal volatility in EPS, while revenue remains relatively stable.  High profit margins indicate strong profitability, although a significant drop in EPS and fluctuations in ROE require further investigation.  Inconsistent data and missing context (e.g., earnings expectations) limit the depth of this analysis.  Additional information regarding recent news and analyst opinions is crucial for a more complete assessment.  The inconsistent EPS figures reported on 2024-10-30 raise serious concerns about data accuracy and need immediate resolution.


**8) Disclaimer:** This report is based solely on the data provided.  It does not constitute financial advice.  Further research and analysis are recommended before making any investment decisions.  The inconsistencies in the provided data warrant further scrutiny and clarification.
